Review | SARS-COV-2 Neutralizing Antibodies

Team Annar
Content creation
SHARE

Review SARS-COV-2 Neutralizing Antibodies

Casa Comercial Asociada: DIA.PRO


Neutralizing antibodies to SARS COV 2 are antibodies capable of stopping the binding of host cell receptors to the virus receptor located on the spicule.

They are relevant because they are the antigenic target for vaccine development, and are responsible for host protection against infection.

Currently there are in vitro diagnostic products that allow the quantification of these IgG isotype antibodies that, when used with responsibility and knowledge, will provide valuable information to improve the management of vaccines and the knowledge of this viral infection.

 

 


 

Most viewed

The Human Perspective on Cancer

Resolution 1811 of 2025

Reactivation of yellow fever cases in Latin America – How to prevent it?

Timely and complete diagnosis: A pillar for quality and efficiency in health care and management